26 September 2018
Antibiotic resistance (AMR) is present everywhere. AMR occurs when microorganisms survive exposure to a medicine that would normally kill them such as antibiotics, antimalarials and antivirals. These microorganisms are often referred to as ‘superbugs’ and can leave medicines ineffective.
Occurring naturally overtime, our misuse and overuse of antibiotics is largely accelerating this global health problem. In 2016, 490 000 people developed multi-drug resistant to TB, and drug resistance is starting to complicate the fight against HIV and malaria as well. As England’s Chief Medical Officer, Professor Dame Sally Davies, warned AMR poses a ‘catastrophic threat’ to the world over.
We are excited to announce our partnership with the Commonwealth Pharmaceutical’s Association which will see up to 12 new Commonwealth Health Partnerships created. Volunteer NHS pharmacists and specialist nurses will travel to participating Commonwealth nations to work in partnership with local health workers to share expertise and jointly tackle the growing challenge of antimicrobial resistance.
The new scheme, funded by UK aid from the Department of Health and Social Care (DHSC), is part of the wider commitment by DHSC to spend up to £245million of UK aid to support low and middle income countries to enhance their surveillance of AMR by 2021, through the Fleming Fund.
“Antimicrobial resistance poses a catastrophic threat to us all and yet until recently it has remained a neglected area of global health.
At THET we believe that working in partnerships is the best way to strengthen health systems both at home and overseas. Through volunteer placements our NHS staff will pass on their expertise to their counterparts in the Commonwealth whilst learning from them and the low-resource settings they spend time within.
We are proud to be a part of this programme and look forward to sharing its successes.”
Ben Simms, CEO – THET
We look forward to announcing further details in the weeks to come!
Leave a commentYour email address will not be published.